Drugs / Vaxigripetra
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05921448 | May 2025 → Jul 2026 overdue | influenza | Copenhagen Respiratory Research | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaxigripetra | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05921448 ↗ |
| Modality | Vaccine | “Tetravalent intramuscular vaccine.” NCT05921448 ↗ |
| Route | Intramuscular | “Vaxigripetra (intra-muscular injection)” NCT05921448 ↗ |